These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15035216)

  • 1. [Abnormality of bone mineral metabolism in type 2 diabetes mellitus].
    Takizawa M; Ishida H; Suzuki K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():723-7. PubMed ID: 15035216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of thyrocalcitonin in osteogenesis].
    Briskin AI
    Ortop Travmatol Protez; 1973 Dec; 34(12):69-71. PubMed ID: 4790654
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--parathyroid hormones and active-type vitamin D 3].
    Matsumoto T; Ogata E
    Nihon Rinsho; 1986 Nov; 44(11):2359-65. PubMed ID: 3029459
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic and biochemical considerations of bone.
    Lutwak L
    Ann Clin Lab Sci; 1975; 5(3):185-94. PubMed ID: 166601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone complication in diabetic subjects with good metabolic control and without any late complications: selected problems. Part I: calcium, phosphorus and magnesium metabolism].
    Zywiec J; Grzeszczak W; Pierzchała K
    Przegl Lek; 2001; 58(5):426-30. PubMed ID: 11603176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Graves' disease and bone metabolism].
    Sato K
    Nihon Rinsho; 2006 Dec; 64(12):2317-22. PubMed ID: 17154099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal regulation of bone metabolism].
    Gera I
    Fogorv Sz; 1993 Apr; 86(4):107-20. PubMed ID: 8243730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current developments in the study of bone and mineral metabolism].
    Herrmann-Erlee MP
    Ned Tijdschr Geneeskd; 1976 Apr; 120(14):614-20. PubMed ID: 176604
    [No Abstract]   [Full Text] [Related]  

  • 9. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
    Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
    J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of increased dietary calcium intake on bone mineral density in long-term lactating women, and recovery of bone loss caused by long-term lactation with low calcium diet].
    Yoneyama K; Ikeda J
    Nihon Koshu Eisei Zasshi; 2004 Dec; 51(12):1008-17. PubMed ID: 15682820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical markers of bone tissue metabolism in cosmonauts after a prolonged spaceflight].
    Morukov BV; Nichiporuk IA; Tret'iakov VS; Larina IM
    Fiziol Cheloveka; 2005; 31(6):73-7. PubMed ID: 16366155
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic nucleotides in bone and mineral metabolism.
    Peck WA; Klahr S
    Adv Cyclic Nucleotide Res; 1979; 11():89-130. PubMed ID: 227250
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone complication in diabetes subjects with good metabolic control and without longterm complications: certain problems. Part II. Basal parameters of bone turnover].
    Zywiec J; Grzeszczak W; Pierzchała K
    Przegl Lek; 2001; 58(6):495-7. PubMed ID: 11816739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus.
    Nakashima A; Nakashima R; Ito T; Masaki T; Yorioka N
    Diabet Med; 2004 Sep; 21(9):1020-4. PubMed ID: 15317608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal renewal and metabolic bone disease.
    Harris WH; Heaney RP
    N Engl J Med; 1969 Jan; 280(5):253-9 contd. PubMed ID: 4883109
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of thyrocalcitonin and parathyroid hormone on bone metabolism in tissue culture. The effect on collagen breakdown in relation to bone demineralization.
    Heersche JN
    Proc K Ned Akad Wet C; 1969; 72(3):286-98. PubMed ID: 4240835
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of serum on the calcitonin-dependent bone resorption in vitro.
    Gozariu L; Bellwinkel S; Ziegler R
    Endocrinol Exp; 1973; 7(2):129-32. PubMed ID: 4541072
    [No Abstract]   [Full Text] [Related]  

  • 18. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
    Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
    J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why is mineral nutrition important in osteoporosis?
    Jowsey J
    Geriatrics; 1978 Aug; 33(8):39-42, 47-8. PubMed ID: 669272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.